Loading…
Loading…
POS1361 THE INFLUENCE OF BASELINE DEMOGRAPHICS ON VARIABILITY OF OA PAIN ASSESSED BY WOMAC PAIN CHANGE FROM BASELINE IN INTERVENTIONAL TRIALS
Bihlet, A. R., Alexandersen, P., Andersen, J. R., Li, Y., Karsdal, M., Miller, C. P.
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
Loading…
Loading…
Analyses of Change from Baseline Heartburn-Free Days in Subjects with Higher vs Lower Heartburn Frequency Treated with Esomeprazole 20 Mg: 508
Johnson, David, Le Moigne, Anne, Wassel, Heather, Pollack, Charles, Nagy, Peter
Published in The American journal of gastroenterology (01.10.2016)
Published in The American journal of gastroenterology (01.10.2016)
Get full text
Journal Article
Loading…
Concentration-effect modeling based on change from baseline to assess the prolonging effect of drugs on QTc together with an estimate of the circadian time course
Ferber, Georg, Wang, Duolao, Täubel, Jörg
Published in Journal of clinical pharmacology (01.12.2014)
Published in Journal of clinical pharmacology (01.12.2014)
Get more information
Journal Article
Loading…
Abstract 13482: Change From Baseline and Initial Post-Chemotherapy Echocardiographic Shortening Fraction Predicts Long-Term Cardiac Dysfunction in Patients With Anthracycline Chemotherapy Exposure
Cole, Jason M, Daniels, Zachary, Mah, May, Lee, Simon, Olshefski, Randal, Tora-Salazar, Olga, Nandi, Deipanjan, Hor, Kan N
Published in Circulation (New York, N.Y.) (19.11.2019)
Published in Circulation (New York, N.Y.) (19.11.2019)
Get full text
Journal Article
Loading…
Loading…
Loading…
Loading…
Clinical Trial: An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA(R) in Opioid Dependent Subjects
Published in US Fed News Service, Including US State News
(16.09.2019)
Get full text
Newsletter
Loading…
Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo‐Controlled Study
Gunawardhana, Lhanoo, McLean, Lachy, Punzi, Henry A., Hunt, Barbara, Palmer, Robert N., Whelton, Andrew, Feig, Daniel I.
Published in Journal of the American Heart Association (01.11.2017)
Published in Journal of the American Heart Association (01.11.2017)
Get full text
Journal Article
Loading…
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging
Flint, Anne, Andersen, Grit, Hockings, Paul, Johansson, Lars, Morsing, Anni, Sundby Palle, Mads, Vogl, Thomas, Loomba, Rohit, Plum‐Mörschel, Leona
Published in Alimentary pharmacology & therapeutics (01.11.2021)
Published in Alimentary pharmacology & therapeutics (01.11.2021)
Get full text
Journal Article
Loading…
Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
Stenlöf, K., Cefalu, W. T., Kim, K.-A., Alba, M., Usiskin, K., Tong, C., Canovatchel, W., Meininger, G.
Published in Diabetes, obesity & metabolism (01.04.2013)
Published in Diabetes, obesity & metabolism (01.04.2013)
Get full text
Journal Article
Loading…
Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective Study
Bickle, Katherine, Miller, Jason R., Tauber, Joseph, Awisi-Gyau, Deborah
Published in Ophthalmology and therapy (01.02.2024)
Published in Ophthalmology and therapy (01.02.2024)
Get full text
Journal Article
Loading…
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin‐Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti‐PCSK9 Antibody in Statin‐Intolerant Subjects 3 (GAUSS‐3) Trial
Nissen, Steven E., Dent‐Acosta, Ricardo E., Rosenson, Robert S., Stroes, Erik, Sattar, Naveed, Preiss, David, Mancini, G.B. John, Ballantyne, Christie M., Catapano, Alberico, Gouni‐Berthold, Ioanna, Stein, Evan A., Xue, Allen, Wasserman, Scott M., Scott, Rob, Thompson, Paul D.
Published in Clinical cardiology (Mahwah, N.J.) (01.03.2016)
Published in Clinical cardiology (Mahwah, N.J.) (01.03.2016)
Get full text
Journal Article
Loading…
Differential impact of the cheese matrix on the postprandial lipid response: a randomized, crossover, controlled trial
Drouin-Chartier, Jean-Philippe, Tremblay, André J, Maltais-Giguère, Julie, Charest, Amélie, Guinot, Léa, Rioux, Laurie-Eve, Labrie, Steve, Britten, Michel, Lamarche, Benoît, Turgeon, Sylvie L, Couture, Patrick
Published in The American journal of clinical nutrition (01.12.2017)
Published in The American journal of clinical nutrition (01.12.2017)
Get full text
Journal Article
Loading…
Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET)
Rosenstock, Julio, Frias, Juan, Páll, Dénes, Charbonnel, Bernard, Pascu, Raluca, Saur, Didier, Darekar, Amanda, Huyck, Susan, Shi, Harry, Lauring, Brett, Terra, Steven G.
Published in Diabetes, obesity & metabolism (01.03.2018)
Published in Diabetes, obesity & metabolism (01.03.2018)
Get full text
Journal Article
Loading…
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
DeFronzo, Ralph A., Lewin, Andrew, Patel, Sanjay, Liu, Dacheng, Kaste, Renee, Woerle, Hans J., Broedl, Uli C.
Published in Diabetes care (01.03.2015)
Published in Diabetes care (01.03.2015)
Get full text
Journal Article